Manufacturers Life Insurance Company, The Concert Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.77 - $5.24 $57,077 - $79,333	-15,140 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$4.86 - $13.07 $24,387 - $65,585	-5,018 Reduced 24.89%	15,140 $76,000
Q4 2020 Feb 12, 2021	BUY	$9.48 - $12.84 $20,154 - $27,297	2,126 Added 11.79%	20,158 $255,000
Q2 2020 Aug 10, 2020	BUY	$7.8 - $11.52 $13,166 - $19,445	1,688 Added 10.33%	18,032 $171,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $13,449 - $29,439	2,249 Added 15.96%	16,344 $144,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $7,520 - $12,142	-1,317 Reduced 8.55%	14,095 $130,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $145,489 - $202,205	15,412 New	15,412 $185,000
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $215,376 - $300,384	-16,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $51,701 - $66,539	3,072 Added 22.38%	16,800 $283,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $8,484 - $12,361	-441 Reduced 3.11%	13,728 $314,000
Q4 2017 Feb 08, 2018	SELL	$13.96 - $29.05 $14,616 - $30,415	-1,047 Reduced 6.88%	14,169 $366,000
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $211,654 - $232,956	15,216	15,216 $225,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.